BeOne Medicines
Phuong Oanh Tran Stephan currently serves as the Executive Director and Head of Global Medical Writing at BeiGene since September 2023. Previously, Phuong held the position of Senior Director of Strategy and Scientific Writing for Immunology and Fibrosis at Bristol Myers Squibb from January 2021 to October 2023, where Phuong led a team of over 10 writers to develop regulatory documents for drug development. Earlier roles include Director of Medical Writing at Allergan, overseeing anti-infectives, internal medicine, urology, and gastroenterology, as well as Associate Director at Bristol-Myers Squibb, focusing on clinical documents for regulatory submissions for the Opdivo project. Phuong's career began as Principal Consultant at P.O. Tran LLC and as a Staff Scientist at the Pacific Northwest Research Institute, with a strong background in pharmacology demonstrated by a Ph.D. from the University of Minnesota Medical School, earned in 1998.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.